» Articles » PMID: 28481056

The Tumor Promoter-activated Protein Kinase Cs Are a System for Regulating Filopodia

Overview
Specialty Cell Biology
Date 2017 May 9
PMID 28481056
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Different protein kinase C (PKC) isoforms have distinct roles in regulating cell functions. The conventional (α, β, γ) and novel (δ, ɛ, η, θ) classes are targets of phorbol ester tumor promoters, which are surrogates of endogenous second messenger, diacylglycerol. The promoter-stimulated disappearance of filopodia was investigated by use of blocking peptides (BPs) that inhibit PKC maturation and/or docking. Filopodia were partially rescued by a peptide representing PKC ɛ hydrophobic sequence, but also by a myristoylated PKC α/β pseudosubstrate sequence, and an inhibitor of T-cell protein tyrosine phosphatase (TC-PTP). The ability to turn over filopodia was widely distributed among PKC isoforms. PKC α and η hydrophobic sequences enhanced filopodia in cells in the absence of tumor promoter treatment. With transcriptional knockdown of PKC α, the content of PKC ɛ predominated over other isoforms. PKC ɛ could decrease filopodia significantly in promoter-treated cells, and this was attributed to ruffling. The presence of PKC α counteracted the PKC ɛ-mediated enhancement of ruffling. The results showed that there were two mechanisms of filopodia downregulation. One operated in the steady-state and relied on PKC α and η. The other was stimulated by tumor promoters and relied on PKC ɛ. Cycles of protrusion and retraction are characteristic of filopodia and are essential for the cell to orient itself during chemotaxis and haptotaxis. By suppressing filopodia, PKC ɛ can create a long-term "memory" of an environmental signal that may act in nature as a mnemonic device to mark the direction of a repulsive signal.

Citing Articles

Candidate proteins interacting with cytoskeleton in cells from the basal airway epithelium .

Olatona O, Choudhury S, Kresman R, Heckman C Front Mol Biosci. 2024; 11:1423503.

PMID: 39139811 PMC: 11319710. DOI: 10.3389/fmolb.2024.1423503.


How filopodia respond to calcium in the absence of a calcium-binding structural protein: non-channel functions of TRP.

Heckman C, Ademuyiwa O, Cayer M Cell Commun Signal. 2022; 20(1):130.

PMID: 36028898 PMC: 9414478. DOI: 10.1186/s12964-022-00927-y.


Activated Protein Kinase C (PKC) Is Persistently Trafficked with Epidermal Growth Factor (EGF) Receptor.

Heckman C, Biswas T, Dimick D, Cayer M Biomolecules. 2020; 10(9).

PMID: 32906765 PMC: 7563713. DOI: 10.3390/biom10091288.


Determination of protein phosphorylation by polyacrylamide gel electrophoresis.

Lee C, Park Y, Min H, Kim Y, Seok Y J Microbiol. 2019; 57(2):93-100.

PMID: 30706340 DOI: 10.1007/s12275-019-9021-y.


The tumor promoter-activated protein kinase Cs are a system for regulating filopodia.

Heckman C, Pandey P, Cayer M, Biswas T, Zhang Z, Boudreau N Cytoskeleton (Hoboken). 2017; 74(8):297-314.

PMID: 28481056 PMC: 5575509. DOI: 10.1002/cm.21373.

References
1.
Wu-Zhang A, Newton A . Protein kinase C pharmacology: refining the toolbox. Biochem J. 2013; 452(2):195-209. PMC: 4079666. DOI: 10.1042/BJ20130220. View

2.
Kielkopf C, Bauer W, Urbatsch I . Expressing Cloned Genes for Protein Production, Purification, and Analysis. Cold Spring Harb Protoc. 2020; 2021(2). DOI: 10.1101/pdb.top102129. View

3.
Liao L, Hyatt S, Chapline C, Jaken S . Protein kinase C domains involved in interactions with other proteins. Biochemistry. 1994; 33(5):1229-33. DOI: 10.1021/bi00171a024. View

4.
Garg R, Benedetti L, Abera M, Wang H, Abba M, Kazanietz M . Protein kinase C and cancer: what we know and what we do not. Oncogene. 2013; 33(45):5225-37. PMC: 4435965. DOI: 10.1038/onc.2013.524. View

5.
Heckman C, Jamasbi R . Describing shape dynamics in transformed cells through latent factors. Exp Cell Res. 1999; 246(1):69-82. DOI: 10.1006/excr.1998.4242. View